Le Lézard15 分钟
BioVaxys Developing DPX to be the Carrier of Choice for mRNA Vaccines, a market projected ...
BioVaxys Technology Corp. (FRA: 5LB) ("BioVaxys" or the "Company") highlights the potential for its DPXtm non-systemic immune educating platform to address the inherent limitations of lipid ...